Is BioVie Inc. (BIVI) a Buy, Sell, or Hold?
NASDAQ : BIVI
BioVie Inc.
$1.8 USD
$0.08 (4.65%)
- Volume
- 92.55K
- Average Volume
- 149.43K
- Market Capitalization
- $13.58M
- P/E Ratio
- -1.22
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.84
- Year Low
- $1.06
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.97
Insider Activity Summary (Last 12 Months)
Insiders Buying
15
Insiders Selling
6
Amount of Insider Selling
$147.54K
BIVI Insider Buying/Selling by Quarter
BIVI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Palumbo Joseph M | officer: Chief Medical Officer | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| ROGICH SIGMUND | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| ROGICH SIGMUND | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| DO CUONG V | director, officer: President & CEO | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Sherman Michael Edward | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Sherman Michael Edward | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Farag Kameel D. | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Chappell Amy Suzon | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Lang James Paul | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Lang James Paul | director | 2026-01-05 | A-Award | 1.31 | 2026-01-09 |
| Farag Kameel D. | director: | 2025-07-17 | 0 | 2025-10-28 | |
| Chappell Amy Suzon | director: | 2025-07-17 | 0 | 2025-10-27 | |
| DO CUONG V | director, officer: President & CEO | 2025-08-07 | P-Purchase | 0 | 2025-08-13 |
| DO CUONG V | director, officer: President & CEO | 2025-08-07 | P-Purchase | 2.5 | 2025-08-13 |
| ROGICH SIGMUND | director | 2024-11-20 | A-Award | 0 | 2025-01-07 |
| ROGICH SIGMUND | director | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| BERMAN RICHARD J | director | 2024-11-20 | A-Award | 0 | 2025-01-07 |
| BERMAN RICHARD J | director | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| Sherman Michael Edward | director | 2024-11-20 | A-Award | 3.36 | 2025-01-07 |
| Sherman Michael Edward | director | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| Lang James Paul | director | 2024-11-20 | A-Award | 3.36 | 2025-01-07 |
| Lang James Paul | director | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| Hariri Robert J | director | 2024-11-20 | A-Award | 3.36 | 2025-01-07 |
| Hariri Robert J | director | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| DO CUONG V | director, officer: President & CEO | 2024-12-20 | A-Award | 1.9 | 2025-01-07 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2024-06-24 | A-Award | 0.474 | 2024-07-12 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2024-06-24 | A-Award | 0 | 2024-07-12 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2024-06-24 | F-InKind | 0.474 | 2024-07-12 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2023-02-16 | F-InKind | 5.51 | 2024-07-12 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2024-02-15 | F-InKind | 1.18 | 2024-07-12 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2024-06-24 | A-Award | 0 | 2024-07-12 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2024-06-24 | A-Award | 0.474 | 2024-07-12 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2024-06-24 | F-InKind | 0.474 | 2024-07-12 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2023-02-16 | F-InKind | 5.51 | 2024-07-12 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2024-02-15 | F-InKind | 1.18 | 2024-07-12 |
| DO CUONG V | director, officer: President & CEO | 2024-06-24 | A-Award | 0 | 2024-07-12 |
| DO CUONG V | director, officer: President & CEO | 2024-06-24 | F-InKind | 0.474 | 2024-07-12 |
| DO CUONG V | director, officer: President & CEO | 2023-02-16 | F-InKind | 5.51 | 2024-07-12 |
| DO CUONG V | director, officer: President & CEO | 2024-02-15 | F-InKind | 1.18 | 2024-07-12 |
| DO CUONG V | director, officer: President & CEO | 2024-06-24 | A-Award | 0.474 | 2024-07-12 |
| DO CUONG V | director, officer: President & CEO | 2024-03-04 | P-Purchase | 1 | 2024-03-06 |
| DO CUONG V | director, officer: President & CEO | 2024-03-04 | P-Purchase | 1.5 | 2024-03-06 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2023-12-11 | A-Award | 0 | 2023-12-13 |
| Lang James Paul | director | 2023-11-09 | A-Award | 3.01 | 2023-12-06 |
| GORLIN STEVE | director | 2023-11-09 | A-Award | 0 | 2023-12-06 |
| GORLIN STEVE | director | 2023-12-01 | S-Sale | 1.69 | 2023-12-06 |
| ROGICH SIGMUND | director | 2023-11-09 | A-Award | 0 | 2023-12-06 |
| Hariri Robert J | director | 2023-11-09 | A-Award | 0 | 2023-12-06 |
| Sherman Michael Edward | director | 2023-11-09 | A-Award | 3.01 | 2023-12-06 |
| BERMAN RICHARD J | director | 2023-11-09 | A-Award | 0 | 2023-12-06 |
| DO CUONG V | director, officer: President & CEO | 2023-11-30 | P-Purchase | 1.78 | 2023-12-01 |
| GORLIN STEVE | director | 2023-09-05 | S-Sale | 3.05 | 2023-09-07 |
| BERMAN RICHARD J | director | 2023-08-22 | S-Sale | 3.5009 | 2023-08-24 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2023-06-07 | A-Award | 5.78 | 2023-07-03 |
| DO CUONG V | director, officer: CEO & President | 2023-06-29 | A-Award | 0 | 2023-07-03 |
| DO CUONG V | director, officer: CEO & President | 2023-06-29 | A-Award | 4.0953 | 2023-07-03 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2023-06-07 | A-Award | 5.78 | 2023-07-03 |
| DO CUONG V | director, officer: CEO & President | 2023-06-21 | M-Exempt | 0 | 2023-06-26 |
| DO CUONG V | director, officer: CEO & President | 2023-06-21 | M-Exempt | 0 | 2023-06-26 |
| BERMAN RICHARD J | director | 2023-05-22 | S-Sale | 6.5012 | 2023-06-15 |
| BERMAN RICHARD J | director | 2023-06-07 | S-Sale | 5.8125 | 2023-06-15 |
| BERMAN RICHARD J | director | 2023-03-27 | S-Sale | 8.517 | 2023-04-06 |
| BERMAN RICHARD J | director | 2023-03-28 | S-Sale | 8.5215 | 2023-04-06 |
| BERMAN RICHARD J | director | 2023-03-28 | S-Sale | 8.52 | 2023-04-06 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2023-02-16 | F-InKind | 6.12 | 2023-02-22 |
| DO CUONG V | director, officer: CEO & President | 2023-02-16 | F-InKind | 6.12 | 2023-02-22 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2023-02-16 | F-InKind | 6.12 | 2023-02-22 |
| Ahlem Clarence N. | officer: EVP Neuroscience Product Dev. | 2023-02-16 | F-InKind | 6.12 | 2023-02-22 |
| READING CHRISTOPHER | officer: EVP Neuroscience R&D | 2023-02-16 | F-InKind | 6.12 | 2023-02-22 |
| MARKHAM PENELOPE | officer: EVP Liver Cirrhosis R&D | 2023-02-16 | F-InKind | 6.12 | 2023-02-22 |
| ROGICH SIGMUND | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| GORLIN STEVE | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| Sherman Michael Edward | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| Lang James Paul | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| READING CHRISTOPHER | officer: EVP Neuroscience R&D | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| Hariri Robert J | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| Palumbo Joseph M | officer: Chief Medical Officer | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| Ahlem Clarence N. | officer: EVP Neuroscience Product Dev. | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| BERMAN RICHARD J | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| PEIZER TERREN S | director | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| KIM JOANNE WENDY | officer: Chief Financial Officer | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| DO CUONG V | officer: CEO & President | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| MARKHAM PENELOPE | officer: EVP Liver Cirrhosis R&D | 2022-11-23 | A-Award | 0 | 2023-01-18 |
| PEIZER TERREN S | director, 10 percent owner: | 2021-06-10 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2020-09-22 | M-Exempt | 0.0001 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2020-09-22 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2020-01-02 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2020-01-02 | A-Award | 13487 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2019-09-24 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2019-06-24 | A-Award | 45 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2018-07-03 | P-Purchase | 2.25 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2019-01-02 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2018-07-03 | P-Purchase | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2018-08-13 | C-Conversion | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2019-09-24 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2020-07-13 | A-Award | 0 | 2022-08-26 |
| PEIZER TERREN S | director, 10 percent owner: | 2020-09-22 | D-Return | 0 | 2022-08-26 |